Publications in collaboration with researchers from Albert Schweitzer Hospital (1)

2010

  1. Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

    Pulmonary Pharmacology and Therapeutics, Vol. 23, Núm. 5, pp. 438-444